Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker
Thioredoxin interacting protein (TXNIP) is a metabolic protein critically involved in redox homeostasis and has been proposed as a tumor suppressor gene in a variety of malignancies. Accordingly, TXNIP is downregulated in breast, bladder, and gastric cancer and in tumor transplant models TXNIP overe...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/3028 |
_version_ | 1797550619768127488 |
---|---|
author | Joana Schröder Udo Schumacher Lukas Clemens Böckelmann |
author_facet | Joana Schröder Udo Schumacher Lukas Clemens Böckelmann |
author_sort | Joana Schröder |
collection | DOAJ |
description | Thioredoxin interacting protein (TXNIP) is a metabolic protein critically involved in redox homeostasis and has been proposed as a tumor suppressor gene in a variety of malignancies. Accordingly, TXNIP is downregulated in breast, bladder, and gastric cancer and in tumor transplant models TXNIP overexpression inhibits growth and metastasis. As TXNIP protein expression has only been investigated in few malignancies, we employed immunohistochemical detection in a large multi-tumor tissue microarray consisting of 2,824 samples from 94 different tumor entities. In general, TXNIP protein was present only in a small proportion of primary tumor samples and in these cases was differently expressed depending on tumor stage and subtype (e.g., renal cell carcinoma, thyroid cancer, breast cancer, and ductal pancreatic cancer). Further, TXNIP protein expression was determined in primary mouse xenograft tumors derived from human cancer cell lines and was immunohistochemically absent in all xenograft tumors investigated. Intriguingly, TXNIP expression became gradually lower in the proximity of the primary tumor tissue and was absent in leukocytes directly adjacent to tumor tissue. In conclusion, these findings suggest that TXNIP downregulation is as a common feature in human tumor xenograft models and that intra-tumoral leukocytes down-regulate TXNIP. Hence TXNIP expression might be used to monitor the functional state of tumor-infiltrating leukocytes in tissue sections. |
first_indexed | 2024-03-10T15:31:53Z |
format | Article |
id | doaj.art-d370cd4ca7bd477a898a44aac916a1ad |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-10T15:31:53Z |
publishDate | 2020-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-d370cd4ca7bd477a898a44aac916a1ad2023-11-20T17:34:47ZengMDPI AGCancers2072-66942020-10-011210302810.3390/cancers12103028Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance MarkerJoana Schröder0Udo Schumacher1Lukas Clemens Böckelmann2Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, GermanyInstitute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, GermanyInstitute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, GermanyThioredoxin interacting protein (TXNIP) is a metabolic protein critically involved in redox homeostasis and has been proposed as a tumor suppressor gene in a variety of malignancies. Accordingly, TXNIP is downregulated in breast, bladder, and gastric cancer and in tumor transplant models TXNIP overexpression inhibits growth and metastasis. As TXNIP protein expression has only been investigated in few malignancies, we employed immunohistochemical detection in a large multi-tumor tissue microarray consisting of 2,824 samples from 94 different tumor entities. In general, TXNIP protein was present only in a small proportion of primary tumor samples and in these cases was differently expressed depending on tumor stage and subtype (e.g., renal cell carcinoma, thyroid cancer, breast cancer, and ductal pancreatic cancer). Further, TXNIP protein expression was determined in primary mouse xenograft tumors derived from human cancer cell lines and was immunohistochemically absent in all xenograft tumors investigated. Intriguingly, TXNIP expression became gradually lower in the proximity of the primary tumor tissue and was absent in leukocytes directly adjacent to tumor tissue. In conclusion, these findings suggest that TXNIP downregulation is as a common feature in human tumor xenograft models and that intra-tumoral leukocytes down-regulate TXNIP. Hence TXNIP expression might be used to monitor the functional state of tumor-infiltrating leukocytes in tissue sections.https://www.mdpi.com/2072-6694/12/10/3028cancerimmunotherapyreactive oxygen speciesthioredoxinthioredoxin interacting proteintissue array |
spellingShingle | Joana Schröder Udo Schumacher Lukas Clemens Böckelmann Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker Cancers cancer immunotherapy reactive oxygen species thioredoxin thioredoxin interacting protein tissue array |
title | Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker |
title_full | Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker |
title_fullStr | Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker |
title_full_unstemmed | Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker |
title_short | Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker |
title_sort | thioredoxin interacting protein txnip is differentially expressed in human tumor samples but is absent in human tumor cell line xenografts implications for its use as an immunosurveillance marker |
topic | cancer immunotherapy reactive oxygen species thioredoxin thioredoxin interacting protein tissue array |
url | https://www.mdpi.com/2072-6694/12/10/3028 |
work_keys_str_mv | AT joanaschroder thioredoxininteractingproteintxnipisdifferentiallyexpressedinhumantumorsamplesbutisabsentinhumantumorcelllinexenograftsimplicationsforitsuseasanimmunosurveillancemarker AT udoschumacher thioredoxininteractingproteintxnipisdifferentiallyexpressedinhumantumorsamplesbutisabsentinhumantumorcelllinexenograftsimplicationsforitsuseasanimmunosurveillancemarker AT lukasclemensbockelmann thioredoxininteractingproteintxnipisdifferentiallyexpressedinhumantumorsamplesbutisabsentinhumantumorcelllinexenograftsimplicationsforitsuseasanimmunosurveillancemarker |